Innovate UK has appointed its first director for health and life sciences, with Ian Campbell taking up the role in Autumn 2016.
In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency’s life sciences and health sector.
Campbell currently serves as chief executive officer of Arquer Diagnostics, a UK based diagnostics company specialising in non-invasive tests for the detection of cancer.
Previously, he was commercial director for Bespak Europe, a medical devices manufacturer, and has served as the chief executive officer of Imperial College spin-out company Molecular Vision, which was acquired by Abingdon Health in 2012.
Dr Ruth McKernan, chief executive of Innovate UK, said: “Ian Campbell will make a strong addition to the team at Innovate UK.
“He has extensive entrepreneurial and business experience which make him well-suited to lead our health and life sciences team as we set out our strategy for supporting innovation and growth over the next five years.”
To find out more about Innovation UK, please go to the website.
